US Stocks Open Higher, Nasdaq Surges Over 100 Points
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more than 100 points on Monday. Following the market opening Monday, the Dow traded up 0.84% to 32,421.64 while the NASDAQ rose 1.14% to 12,249.84. The SP 500 also rose, gaining, 1.04% to 4,109.73. Also check this: Volatility In Markets Drops After US Stocks Record Weekly Gains Leading and Lagging Sectors Energy shares jumped by 2.5% on Monday. Meanwhile, top gainers in the sector included Borr Drilling Limited (NYSE: BORR ), up 8% and Dynagas LNG Partners LP (NYSE: DLNG ) up 6%. In trading on Monday, utilities shares rose by just 0.01%. Top Headline Yum! Brands Inc (NYSE: YUM ) Board of Directors approved a new share repurchase authorization for up to $2 billion in shares of common stock through June 30, 2024. Equities Trading UP Ventyx Biosciences, Inc. (NASDAQ: VTYX ) shares shot up 71% to $39.54 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65. Shares of InMed Pharmaceuticals Inc. (NASDAQ: INM ) got a boost, shooting …
US Stocks Open Higher, Nasdaq Surges Over 100 Points
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more than 100 points on Monday. Following the market opening Monday, the Dow traded up 0.84% to 32,421.64 while the NASDAQ rose 1.14% to 12,249.84. The SP 500 also rose, gaining, 1.04% to 4,109.73. Also check this: Volatility In Markets Drops After US Stocks Record Weekly Gains Leading and Lagging Sectors Energy shares jumped by 2.5% on Monday. Meanwhile, top gainers in the sector included Borr Drilling Limited (NYSE: BORR ), up 8% and Dynagas LNG Partners LP (NYSE: DLNG ) up 6%. In trading on Monday, utilities shares rose by just 0.01%. Top Headline Yum! Brands Inc (NYSE: YUM ) Board of Directors approved a new share repurchase authorization for up to $2 billion in shares of common stock through June 30, 2024. Equities Trading UP Ventyx Biosciences, Inc. (NASDAQ: VTYX ) shares shot up 71% to $39.54 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65. Shares of InMed Pharmaceuticals Inc. (NASDAQ: INM ) got a boost, shooting …